Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Megan E. Laycock"'
Autor:
John W. Heitman, Michael P. Busch, Joan D. McAuley, Megan E. Laycock, David Wright, Yongling Tu, Dale F. Hirschkorn, Steven Kleinman, James Gallarda, Cristina Giachetti, Simone A. Glynn
Publikováno v:
Transfusion. 45:1853-1863
BACKGROUND: Screening donors for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) RNA is primarily performed on minipools (MPs) with one of two commercial nucleic acid amplification tests (NAT; Roche Molecular Systems; or Gen-Probe/Chir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a0d51cca16910d0fb44b38c8eea0a56
https://doi.org/10.1111/j.1537-2995.2005.00649.x
https://doi.org/10.1111/j.1537-2995.2005.00649.x
Autor:
Beth A. Mohr, W. Lawrence Drew, Michael P. Busch, Susan F. Assmann, R C Miner, Megan E. Laycock, Sunwen Chou
Publikováno v:
Transfusion. 43:1351-1357
BACKGROUND: The Viral Activation Transfusion Study (VATS) afforded an opportunity to determine whether blood transfusions, and in particular exogenous WBCs, “activate” CMV replication in HIV-infected, CMV-seropositive patients, and whether such p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1c0239bd59a8014744f7a6e4c4ce7c0
https://doi.org/10.1046/j.1537-2995.2003.00520.x
https://doi.org/10.1046/j.1537-2995.2003.00520.x
Autor:
Christopher D. Hillyer, W. Lawrence Drew, Megan E. Laycock, Michael P. Busch, Deborah Todd, John D. Roback
Publikováno v:
Transfusion. 43:314-321
BACKGROUND : Although serologic screening or WBC reduction of blood components can reduce the incidence of transfusion-transmitted CMV (TT-CMV) infection, ‘breakthrough’ cases of TT-CMV still occur and may produce serious sequelae. NAT of blood c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0a5830a1d756208313a52e70926b012
https://doi.org/10.1046/j.1537-2995.2003.00312.x
https://doi.org/10.1046/j.1537-2995.2003.00312.x
Autor:
Hiromichi Ariga, Megan E. Laycock, Beth A. Mohr, Roslyn Yomtovian, Michael P. Busch, Terry Gernsheimer, Leslie A. Kalish, Tzong-Hae Lee
Publikováno v:
Transfusion. 43:98-106
BACKGROUND : New-generation RBC filters reduce WBC concentrations by 4 to 5 logs and may prevent or decrease transfusion complications such as HLA alloimmunization, nonhemolytic febrile reaction, and transfusion-transmitted infections. The residual l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf42bba96e9eeb65486e43018c2d12b2
https://doi.org/10.1046/j.1537-2995.2003.00270.x
https://doi.org/10.1046/j.1537-2995.2003.00270.x
Autor:
James W. Smith, Alan E. Williams, Chou-Pong Pau, M.P. Busch, Steve Kleinman, L. L. L. Lee, Megan E. Laycock, George B. Schreiber, H.E. Ownby
Publikováno v:
Transfusion. 36:37-44
Background: Follow-up studies from the mid-1980s showed that 1 to 5 percent of blood donors testing reactive in anti-human immunodeficiency virus type 1 (HIV-1) enzyme immunoassay (EIA) and testing indeterminate in Western blot were infected with HIV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cb95024c72fd4bed4961d546f9ef69f
https://doi.org/10.1046/j.1537-2995.1996.36196190513.x
https://doi.org/10.1046/j.1537-2995.1996.36196190513.x
Autor:
Steven Kleinman, Jonathan E. Kaplan, Rima F. Khabbaz, Charles G. Hollingsworth, John W. Wages, Michael Calabro, Michael P. Busch, Megan E. Laycock
Publikováno v:
Blood. 83:1143-1148
Blood donations in the United States have been screened for antibody to human T-lymphotropic virus type I (HTLV-I) by HTLV-I enzyme immunoassay (EIA) since November 1988. Specimens repeatedly found to be reactive by EIA undergo confirmation by supple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3dad673e862993c78c043bfc42cdb75
https://doi.org/10.1182/blood.v83.4.1143.1143
https://doi.org/10.1182/blood.v83.4.1143.1143
Autor:
Claudia Cortese Barreto, Brandee L. Pappalardo, Megan E. Laycock, Thelma T. Gonçalez, Ester Cerdeira Sabino, Nanci A. Salles, Dalton de Alencar Fischer Chamone, Michael P. Busch, David Wright
Publikováno v:
Transfusion. 45(11)
BACKGROUND: Concerted efforts have been directed toward recruitment of community rather than replacement donors in Brazil. Time trends and demographic correlates of human immunodeficiency (HIV) prevalence and incidence among first-time (FT) donors in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cd94a22cd252199bb6fd56728368d32
https://pubmed.ncbi.nlm.nih.gov/16271094
https://pubmed.ncbi.nlm.nih.gov/16271094
Autor:
W Lawrence, Drew, Sunwen, Chou, Beth A, Mohr, Susan F, Assmann, Richard C, Miner, Megan E, Laycock, Michael P, Busch
Publikováno v:
Transfusion. 43(10)
The Viral Activation Transfusion Study (VATS) afforded an opportunity to determine whether blood transfusions, and in particular exogenous WBCs, "activate" CMV replication in HIV-infected, CMV-seropositive patients, and whether such patients can be s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::174bcfa73c97f85ce5001f483f994c02
https://pubmed.ncbi.nlm.nih.gov/14507264
https://pubmed.ncbi.nlm.nih.gov/14507264
Autor:
Charles van der Horst, David M. Asmuth, Michael P. Busch, Beth A. Mohr, Leslie A. Kalish, Megan E. Laycock
Publikováno v:
Antiviral research. 63(2)
Chronic infection with either hepatitis B (HBV) or hepatitis C virus (HCV) is frequently present in patients seropositive for human immunodeficiency virus (HIV) because of shared routes of transmission. With the advent of highly active antiretroviral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a1509f61a94370c778859db6386a68
https://pubmed.ncbi.nlm.nih.gov/15302141
https://pubmed.ncbi.nlm.nih.gov/15302141
Autor:
George B. Schreiber, Richard Smith, Eberhard W. Fiebig, Edward Tabor, George J. Nemo, Michael P. Busch, Robin Biswas, Megan E. Laycock, Peddada Lorraine B, Jay S. Epstein, David J. Wright, Chu Chieh Hsia
Publikováno v:
Transfusion. 43(6)
BACKGROUND: A study was designed to estimate relative analytic sensitivity and window-period (WP) closure and to project incremental yield of newer HBsAg tests, pooled-sample NAT, and single-sample NAT, compared to currently licensed HBsAg tests. STU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67549e3d681ded2e34ccbdc28009a1f4
https://pubmed.ncbi.nlm.nih.gov/12757531
https://pubmed.ncbi.nlm.nih.gov/12757531